Question 1

How many shares of ALXN does Candriam S.C.A. own?

Accepted Answer

Candriam S.C.A. previously held 0 shares of ALXN (ALEXION PHARMACEUTICALS INC) before exiting the position in 2021-Q3.

Question 2

What is Candriam S.C.A.'s ALXN position worth?

Accepted Answer

Candriam S.C.A.'s ALXN position was last reported at $0 in 2021-Q3 before the exit.

Question 3

Is Candriam S.C.A. buying or selling ALXN?

Accepted Answer

In 2021-Q3, Candriam S.C.A. exited their ALXN position entirely (-100.0% change in shares).

Question 4

When did Candriam S.C.A. first buy ALXN?

Accepted Answer

Based on available 13F filings, Candriam S.C.A. first reported a position in ALXN in 2019-Q1. They have held the position across 11 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2021-Q3 Latest	Exited	0	-100.0%	$0	0.0%	—	0
2021-Q2	Decreased	503,510	-17.5%	$92.5M	0.6%	—	0
2021-Q1	Unchanged	610,282	0.0%	$91.6M	0.8%	—	0
2020-Q4	Increased	610,282	+8.4%	$95.4M	0.8%	—	46
2020-Q3	Decreased	563,072	-0.2%	$64.4M	0.6%	—	0
2020-Q2	Decreased	564,099	-2.0%	$63.3M	0.7%	—	0
2020-Q1	Unchanged	575,794	0.0%	$60.9M	0.7%	—	0
2019-Q4	Decreased	575,794	-8.9%	$62.3M	0.7%	—	0
2019-Q3	Increased	631,766	+11.8%	$61.9M	0.8%	—	46
2019-Q2	Increased	565,233	+0.0%	$73.7M	0.9%	—	42
2019-Q1	New	565,052	-	$76.4M	1.0%	—	58

ALXN11 quarters

ALXN
11 quarters